Original language | English |
---|---|
Pages (from-to) | 294-295 |
Number of pages | 2 |
Journal | Medical Journal of Australia |
Volume | 205 |
Issue number | 7 |
DOIs |
|
Publication status | Published - 3 Oct 2016 |
Biosimilars in inflammatory bowel disease: Cost savings are welcome but evidence supporting equivalence of biosimilar and originator drugs is currently limited
Research output: Contribution to journal › Comment / Debate › Other › peer-review
1
Citation
(Scopus)